公开(公告)号：US07057049B2

公开(公告)日：2006-06-06

申请号：US10406150

申请日：2003-04-01

Applicant: Kimberley C. Allen ,  Dennis K. Anderson ,  John E. Baldus ,  Todd Boehlow ,  Jerry D. Clark ,  Dan R. Dukesherer ,  Albert D. Edney ,  Tom Fevig ,  Sastry Kunda ,  Jon P. Lawson ,  Patrick H. Lau ,  Lisa L. McDermott ,  Michael K. Mao ,  Jodi L. Moe ,  Partha Mudipalli ,  Win Naing ,  Shaun R. Selness ,  Christine B. Seymour ,  Tobin C. Schilke ,  Shekhar Viswanath ,  John K. Walker ,  Gopichand Yalamanchili

Inventor： Kimberley C. Allen ,  Dennis K. Anderson ,  John E. Baldus ,  Todd Boehlow ,  Jerry D. Clark ,  Dan R. Dukesherer ,  Albert D. Edney ,  Tom Fevig ,  Sastry Kunda ,  Jon P. Lawson ,  Patrick H. Lau ,  Lisa L. McDermott ,  Michael K. Mao ,  Jodi L. Moe ,  Partha Mudipalli ,  Win Naing ,  Shaun R. Selness ,  Christine B. Seymour ,  Tobin C. Schilke ,  Shekhar Viswanath ,  John K. Walker ,  Gopichand Yalamanchili

IPC: C07D231/12 ,  C07D211/06 ,  C07D211/16

CPC classification number: C07D401/06 ,  C07D401/14

Abstract: This invention is directed generally to a process for making substituted pyrazoles, tautomers of the substituted pyrazoles, and salts of the substituted pyrazoles and tautomers. The substituted pyrazoles correspond in structure to Formula (I): wherein R3A, R3B, R3C, Y1, Y2, Y3, Y4, and Y5 are as defined in the specification.

Abstract translation: 本发明一般涉及制备取代的吡唑，取代的吡唑的互变异构体和取代的吡唑和互变异构体的盐的方法。 取代的吡唑在结构上对应于式（I）：其中R 3A，R 3B，R 3C，Y 1， Y 2，Y 2，Y 3，Y 4和Y 5如说明书中所定义。